Rachana R,
Khushi Sharma,
- Professor Department of Biotechnology, Jaypee Institute of Information Technology, Sector 62, NOIDA,India Uttar Pradesh India
- Research scholar Department of Biotechnology, Jaypee Institute of Information Technology, Sector 62, NOIDA,India Uttar Pradesh India
Abstract
Diabetes is a severe chronic disorder with hyperglycemia, either due to dysfunctional pancreas(Type I) or due to malfunctioned glucose utilizing entities like: liver, straight muscle or adipocytes (Type II). Type 1 or Insulin-dependent/Juvenile diabetes and Type 2 Diabetes Mellitus or Non-Insulin dependent/Adult-onset diabetes are the two broad classifications of diabetes. In case of type 1 diabetes injectable insulin is the major form of medication given and in case of Type 2 DM, α-glucosidase inhibitors, insulin sensitizers, SGLT2, insulin secretagogues, biguanides, amylin antagonists, incretin mimetics, and inhibitors are majorly used. Monotherapy and combination therapies are the preferred therapies to manage type 2 diabetes nowadays. Conventional antidiabetic drugs majorly lack cost effectiveness and have side effects and so the world is now again shifting towards using traditional medications based on natural products. Traditional drugs also have many complexities such as: low bioavailability, small shelf life and non-targetability. To address such issues in both the cases of modern day medicine or natural products based medicines: nanotechnology-based drug delivery systems are being devised. The present review introduces the basics of diabetes and discusses nanotechnology-based drug delivery for diabetic patients, majorly for natural products based antidiabetic.
Keywords: Diabetes, Nano therapeutics, Nanotechnology, Phytotherapeutics
[This article belongs to Nano Trends-A Journal of Nano Technology & Its Applications(nts)]
References
- Choudhury H, Pandey M, Hua CK, Mun CS, Jing JK, Kong L, et al. An update on natural compounds in the remedy of diabetes mellitus: A systematic review. J Tradit Complement Med. 2018 May; 8(3):361–76.
- Rossi MC, Nicolucci A, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, et al. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. Nutrition, Metabolism and Cardiovascular Diseases. 2019 May; 29(7):736–43.
- Millán-Guerrero RO, Vásquez C, Isaias-Millán S, Trujillo-Hernández B, Caballero-Hoyos R. [Association between neuropathy and peripheral vascular insufficiency in patients with diabetes mellitus type 2]. Rev Invest Clin. 2011; 63(6):621–9.
- Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, et al. The Effect of Lifestyle Intervention and Metformin on Preventing or Delaying Diabetes Among Women With and Without Gestational Diabetes: The Diabetes Prevention Program Outcomes Study 10-Year Follow-Up. J Clin Endocrinal Metab. 2015 May; 100(4):1646–53.
- Tiwari P. Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update. J Diabetes Res. 2015; 2015:1–11.
- Samadder A. Nano technological approaches in diabetes treatment: A new horizon. World J Transl Med. 2014; 3(2):84.
- Poznyak A, Grechko A V, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020 May; 21(5):1835.
- Roith D Le, Zick Y. Recent Advances in Our Understanding of Insulin Action and Insulin Resistance. Diabetes Care. 2001 May;24(3):588–97
- Lai WF. Development of Hydrogels with Self-Healing Properties for Delivery of Bioactive Agents. Molecular Pharmaceutics. 2021 May 3; 18(5):1833–41.
- Jain S, Saraf S. Type 2 diabetes mellitus—its global prevalence and therapeutic strategies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2010 May; 4(1):48–56.
- Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, et al. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes. JAMA. 2016 May; 316(3):313.
- Noctor E, Crowe C, Carmody LA, Saunders JA, Kirwan B, O’Dea A, et al. Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of Diabetes and Pregnancy Study Groups criteria. Eur J Endocrinal. 2016 May;175(4):287–97
- Hollander MH, Paarlberg KM, Huisjes AJM. Gestational Diabetes: A Review of the Current Literature and Guidelines. Obstet Gynecol Surv. 2007 May; 62(2):125–36.
- Patel MB, Mishra S. Hypoglycemic activity of alkaloidal fraction of Tinospora cordifolia. Phytomedicines. 2011 May; 18(12):1045–52.
- Zolkepli H, Widodo RT, Mahmood S, Salim N, Awang K, Ahmad N, et al. A Review on the Delivery of Plant-Based Antidiabetic Agents Using Nanocarriers: Current Status and Their Role in Combating Hyperglycemia. Polymers (Basel). 2022 Jul 24;14(15):2991
- Kambale EK, Quetin-Leclercq J, Memvanga PB, Beloqui A. An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations. Pharmaceutics. 2022 Oct 8; 14(10).
- Khutami C, Sumiwi SA, Khairul Ikram NK, Muchtaridi M. The Effects of Antioxidants from Natural Products on Obesity, Dyslipidemia, Diabetes and Their Molecular Signaling Mechanism. International journal of molecular sciences. 2022 Feb 12; 23(4).
- Shoaib A, Darraj A, Khan ME, Azmi L, Alalwan A, Alamri O, et al. A Nanotechnology-Based Approach to Biosensor Application in Current Diabetes Management Practices. Nanomaterials. 2023 May; 13(5):867.
- Natarajan J V, Nugraha C, Ng XW, Venkatraman S. Sustained-release from nanocarriers: a review. Journal of Controlled Release. 2014 May; 193:122–38.
- Brasiunas B, Popov A, Ramanavicius A, Ramanaviciene A. Gold nanoparticle based colorimetric sensing strategy for the determination of reducing sugars. Food Chem. 2021 May; 351:129238.
- Mandal D, Sarmah JK, and Gupta J. Nano Revolution: Pioneering Applications of Nanotechnology in Type II Diabetes Care. In: ASEC 2023. Basel Switzerland: MDPI; 2023. p. 56.
- Dewanjee S, Chakraborty P, Mukherjee B, de Feo V. Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy. International Journal of Molecular Sciences. 2020 Mar 23; 21(6):2217.
- Memvanga PB, Nkanga CI. Liposomes for malaria management: the evolution from 1980 to 2020. Malaria Journal. 2021 Jul 27; 20(1):327.
- Taghavi Fardood S, Ramazani A, Moradi S, Azimzadeh Asiabi P. Green synthesis of zinc oxide nanoparticles using arabic gum and photcatalytic degradation of direct blue 129 dye under visible light. Journal of Materials Science: Materials in Electronics. 2017 Sep 27; 28(18):13596–601.
- Alomari G, Hamdan S, Al-Trad B. Gold nanoparticles as a promising treatment for diabetes and its complications: Current and future potentials. Brazilian Journal of Pharmaceutical Sciences. 2021; 57.
- Begines B, Ortiz T, Pérez-Aranda M, Martinez G, Merinero M, Argüelles-Arias F, et al. Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials. 2020 Jul 19;10(7):1403.
- Sur S, Rathore A, Dave V, Reddy KR, Chauhan RS, Sadhu V. Recent developments in functionalized polymer nanoparticles for efficient drug delivery system. Nano-Structures & Nano-Objects. 2019 Oct; 20:100397.
- Anderson JW, Kendall CWC, Jenkins DJA. Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies. J Am Coll Nutr. 2003 May; 22(5):331–9.
- Anderson JW, Kendall CWC, Jenkins DJA. Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies. J Am Coll Nutr. 2003 May; 22(5):331–9.
- Mukhopadhyay P, Maity S, Mandal S, Chakraborti AS, Prajapati AK, Kundu PP. Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment. Carbohydr Polym. 2018 Feb; 182:42–51.
- Nakmode D, Bhavana V, Thakor P, Madan J, Singh PK, Singh SB, et al. Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development. Pharmaceutics. 2022 Apr 11; 14(4):831.
- Talegaonkar S, Bhattacharyya A. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability. AAPS PharmSciTech. 2019 Apr 25;20(3):121.
- Kyriakoudi A, Spanidi E, Mourtzinos I, Gardikis K. Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications. Plants. 2021 Jun 18;10(6):1238.
- Gauttam V, Kalia A. Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system. J Adv Pharm Technol Res. 2013; 4(2):108.
- Hu M, Gou T, Chen Y, Xu M, Chen R, Zhou T, et al. A Novel Drug Delivery System: Hyodeoxycholic Acid-Modified Metformin Liposomes for Type 2 Diabetes Treatment. Molecules. 2023 Mar 8; 28(6):2471.
- Kambale EK, Quetin-Leclercq J, Memvanga PB, Beloqui A. An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations. Pharmaceutics. 2022 Oct 8; 14(10):2135.
- Yu F, Li Y, Chen Q, He Y, Wang H, Yang L, et al. Monodisperse micro particles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency. European Journal of Pharmaceutics and Bio pharmaceutics. 2016 Jun; 103:136–48.
- Riva A, Ronchi M, Petrangolini G, Bosisio S, Allegrini P. Improved Oral Absorption of Quercetin from Quercetin Phytosomes®, a New Delivery System Based on Food Grade Lecithin. Eur J Drug Metab Pharmacokinet. 2019 May; 44(2):169–77.
- Rathee S, Kamboj A. Optimization and development of antidiabetic phytosomes by the Box–Behnken design. J Liposome Res. 2018 Apr 3; 28(2):161–72.
- PK S, P S, A J, M C, A B. Anti-Diabetic Activity of Lycopene Niosomes: Experimental Observation. Journal of Pharmaceutics and Drug Development. 2017 Nov;4(1).
- Kamble B, Talreja S, Gupta A, Patil D, Pathak D, Moothedath I, et al. Development and Biological Evaluation of Gymnema Sylvestre Extract-Loaded Nonionic Surfactant-Based Niosomes. Nanomedicine. 2013 May;8(8):1295–305
- Fernandez Garcia R, Lalatsa A, Statts L, Bolas Fernandez F, Ballesteros MP, Serrano DR. Transfersomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale. Int J Pharm. 2020 Jan; 573:118817.
- LEONYZA A, SURINI S. OPTIMIZATION OF SODIUM DEOXYCHOLATE-BASED TRANSFERSOMES FOR PERCUTANEOUS DELIVERY OF PEPTIDES AND PROTEINS. International Journal of Applied Pharmaceutics. 2019 Jul 4; 329–32.
- Abdallah MH, Abu Lila AS, Shawky SM, Almansour K, Alshammari F, Khafagy ES, et al. Experimental Design and Optimization of Nano-Transfersomal Gel to Enhance the Hypoglycemic Activity of Silymarin. Polymers (Basel). 2022 Jan 27; 14(3):508.
- Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. European Journal of Pharmaceutics and Biopharmaceutics. 2018 May; 133:285–308.
- Xue M, Yang M xing, Zhang W, Li X min, Gao D hong, Ou Z min, et al. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles. Int J Nanomedicine. 2013 May; 4677.
- Joshi K, Chandra A, Jain K, Talegaonkar S. Nanocrystalization: An Emerging Technology to Enhance the Bioavailability of Poorly Soluble Drugs. Pharmaceutical Nanotechnology. 2019 Sep 24; 7(4):259–78.
- Shi F, Wei Z, Zhao Y, Xu X. Nanostructured lipid carriers loaded with baicalin: An efficient carrier for enhanced antidiabetic effects. Pharmacognosy Magazine. 2016; 12(47):198.
- Liu L, Tang Y, Gao C, Li Y, Chen S, Xiong T, et al. Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Colloids Surf B Biointerfaces. 2014 May; 115:125–31.
- Anton N, Vandamme TF. Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences. Pharmaceutical Research. 2011 May 6; 28(5):978–85.
- Paul D, Dey TK, Mukherjee S, Ghosh M, Dhar P. Comparative prophylactic effects of α-eleostearic acid rich nano and conventional emulsions in induced diabetic rats. J Food Sci Technol. 2014 May; 51(9):1724–36.
- DJAMIL R, ZAIDAN S, RAHMAT D, PRATAMI DK, HAKIM F. NANOEMULSION OF OKRA FRUIT EXTRACT AS ANTIDIABETIC TREATMENT. International Journal of Applied Pharmaceutics. 2020 May; 138–42.
- Javadi S, Kazemi NM, Halabian R. Preparation of O/W nano-emulsion containing nettle and fenugreek extract and cumin essential oil for evaluating antidiabetic properties. AAPS Open. 2021 May; 7(1):13
- Garg V, Kaur P, Gulati M, Singh SK, Kumar B, Pandey NK, et al. Coadministration of Polypeptide-k and Curcumin Through Solid Self-Nanoemulsifying Drug Delivery System for Better Therapeutic Effect Against Diabetes Mellitus: Formulation, Optimization, Biopharmaceutical Characterization, and Pharmacodynamic Assessment. Assay Drug Dev Technol. 2019 Jun;17(4):201–21
- Joshi RP, Negi G, Kumar A, Pawar YB, Munjal B, Bansal AK, et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: An insight into its mechanism for neuroprotection. Nanomedicine: Nanotechnology, Biology and Medicine. 2013 Aug; 9(6):776–85.
- Balata G, Eassa E, Shamrool H, Zidan S, Rehab MA. Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol. Drug Des Devel Ther. 2016 May; 117.
- Hayati F, Chabib L, Darma DD. Antihyperglycemic activity of self-nano emulsifying drug-delivery systems (SNEDDS) of Ipomoea reptans, Poir leaf ethanolic extract in zebrafish (Danio rerio). In 2018. p. 20026.
- Singh J, Dutta T, Kim KH, Rawat M, Samddar P, Kumar P. ‘Green’ synthesis of metals and their oxide nanoparticles: applications for environmental remediation. Journal of Nano biotechnology. 2018 Dec 30; 16(1):84.
- Khandel P, Yadaw RK, Soni DK, Kanwar L, Shahi SK. Biogenesis of metal nanoparticles and their pharmacological applications: present status and application prospects. Journal of Nanostructure in Chemistry. 2018 Sep 11; 8(3):217–54.
- Ashwini D, Mahalingam G. Green Synthesized Metal Nanoparticles, Characterization and its Antidiabetic activities-A Review. Research Journal of Pharmacy and Technology. 2020; 13(1):468.
- Singh J, Dutta T, Kim KH, Rawat M, Samaddar P, Kumar P. ‘Green’ synthesis of metals and their oxide nanoparticles: applications for environmental remediation. J Nanobiotechnology. 2018 May; 16(1):84.
- Balan K, Qing W, Wang Y, Liu X, Palvannan T, Wang Y, et al. Antidiabetic activity of silver nanoparticles from green synthesis using Lonicera japonica leaf extract. RSC Adv. 2016; 6(46):40162–8.
- Jini D, Sharmila S, Anitha A, Pandian M, Rajapaksha RMH. In vitro and in silico studies of silver nanoparticles (AgNPs) from Allium sativum against diabetes. Sci Rep. 2022 Dec 21; 12(1):22109.
- Anbazhagan P, Murugan K, Jaganathan A, Sujitha V, Samidoss CM, Jayashanthani S, et al. Mosquitocidal, Antimalarial and Antidiabetic Potential of Musa paradisiaca-Synthesized Silver Nanoparticles: In Vivo and In Vitro Approaches. J Clust Sci. 2017 May; 28(1):91–107.
- Sati SC, Kour G, Bartwal AS, Sati MD. Biosynthesis of Metal Nanoparticles from Leaves of Ficus palmata and Evaluation of Their Anti-inflammatory and Anti-diabetic Activities. Biochemistry. 2020 Aug 25; 59(33):3019–25.
- Kambale EK, Quetin-Leclercq J, Memvanga PB, Beloqui A. An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations. Pharmaceutics. 2022 Oct 8; 14(10):2135.
- Rehana D, Mahendiran D, Kumar RS, Rahiman AK. In vitro antioxidant and antidiabetic activities of zinc oxide nanoparticles synthesized using different plant extracts. Bioprocess and Biosystems Engineering. 2017 Jun 30; 40(6):943–57.
- Kitture R, Chordiya K, Gaware S, Ghosh S, More PA, Kulkarni P, et al. ZnO Nanoparticles-Red Sandalwood Conjugate: A Promising Anti-Diabetic Agent. J Nanosci Nanotechnol. 2015 Jun 1; 15(6):4046–51.
- Adibian F, Ghaderi RS, Sabouri Z, Davoodi J, Kazemi M, Ghazvini K, et al. Green synthesis of selenium nanoparticles using Rosmarinus officinalis and investigated their antimicrobial activity. BioMetals. 2022 Feb 12; 35(1):147–58.
- Fan D, Li L, Li Z, Zhang Y, Ma X, Wu L, et al. Biosynthesis of selenium nanoparticles and their protective, antioxidative effects in streptozotocin induced diabetic rats. Science and Technology of Advanced Materials. 2020 Jan 31; 21(1):505–14.
- Deng W, Wang H, Wu B, Zhang X. Selenium-layered nanoparticles serving for oral delivery of Phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect. Acta Pharm Sin B. 2019 Jan; 9(1):74–86.
- Liu Y, Zeng S, Liu Y, Wu W, Shen Y, Zhang L, et al. Synthesis and antidiabetic activity of selenium nanoparticles in the presence of polysaccharides from Catathelasma ventricosum. Int J Biol Macromol. 2018 May; 114: 632–9.
- Vijayakumar S, Vinayagam R, Anand MAV, Venkatachalam K, Saravanakumar K, Wang MH, et al. Green synthesis of gold nanoparticle using Eclipta alba and its antidiabetic activities through regulation of Bcl-2 expression in pancreatic cell line. J Drug Deliv Sci Technol. 2020 May; 58: 101786.
- Badeggi U, Ismail E, Adeloye A, Botha S, Badmus J, Marnewick J, et al. Green Synthesis of Gold Nanoparticles Capped with Procyanidins from Leucosidea sericea as Potential Antidiabetic and Antioxidant Agents. Biomolecules. 2020 May; 10(3):452.
- Venkatachalam M, Govindaraju K, Sadiq AM, Tamilselvan S, Kumar VG, Singaravelu G. Functionalization of gold nanoparticles as antidiabetic nanomaterials. Spectrochim Acta A Mol Biomol Spectrosc. 2013 May; 116:331–8.
- Opris R, Tatomir C, Olteanu D, Moldovan R, Moldovan B, David L, et al. The effect of Sambucus nigra L. extract and phytosynthesized gold nanoparticles on diabetic rats. Colloids Surf B Biointerfaces. 2017 May; 150:192–200.
- Ashwini D, Mahalingam G. Green Synthesized Metal Nanoparticles, Characterization and its Antidiabetic activities-A Review. Res J Pharm Technol. 2020; 13(1):468.
- Hazarika M, Boruah PK, Pal M, Das MR, Tamuly C. Synthesis of Pd‐rGO Nanocomposite for the Evaluation of In Vitro Anticancer and Antidiabetic Activities. Chemistry Select. 2019 Jan 31;4(4):1244–50.
- U R S, C R RK, M S KM, Betageri VS, M S L, Veerapur R, et al. Biogenic Synthesis of NiO Nanoparticles Using Areca catechu Leaf Extract and Their Antidiabetic and Cytotoxic Effects. Molecules. 2021 Apr 22; 26(9):2448.
- Amjadi S, Mesgari Abbasi M, Shokouhi B, Ghorbani M, Hamishehkar H. Enhancement of therapeutic efficacy of Betanin for diabetes treatment by liposomal nanocarriers. Journal of Functional Foods. 2019 Aug; 59:119–28.
- Wang Q, Wei C, Weng W, Bao R, Adu-Frimpong M, Toreniyazov E, et al. Enhancement of oral bioavailability and hypoglycemic activity of Liquiritin-loaded precursor liposome. Int J Pharm. 2021 May; 592:120036.
- Ahangarpour A, Oroojan AA, Khorsandi L, Kouchak M, Badavi M. Solid Lipid Nanoparticles of Myricitrin Have Antioxidant and Antidiabetic Effects on Streptozotocin-Nicotinamide-Induced Diabetic Model and Myotube Cell of Male Mouse. Oxidative Medicine and Cellular Longevity. 2018 Jul 17; 2018:1–18.
- Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: an advanced mode of drug delivery system. 3 2015 Apr; 5(2):123–7.
- Umrani RD, Paknikar KM. Zinc Oxide Nanoparticles Show Antidiabetic Activity in Streptozotocin-Induced Type 1 and 2 Diabetic Rats. Nanomedicine. 2014 Jan 19; 9(1):89–104.
Nano Trends-A Journal of Nano Technology & Its Applications
Volume | 26 |
Issue | 01 |
Received | July 3, 2024 |
Accepted | July 26, 2024 |
Published | July 31, 2024 |